Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01731470 · ClinicalTrials.gov registry record · NA

Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)

A NA study of Interstitial Cystitis and Pelvic Pain, sponsored by Kenneth Peters, MD.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT01731470 is a NA study of Interstitial Cystitis and Pelvic Pain that has completed, run by Kenneth Peters, MD. The registered enrollment target is 14 participants, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01731470, a NA study of Interstitial Cystitis and Pelvic Pain, has completed, sponsored by Kenneth Peters, MD.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Interstitial cystitis/painful bladder syndrome (IC/PBS) is a poorly understood chronic disorder of unknown etiology consisting of irritative bladder symptoms and pelvic pain that dramatically affects quality of life. Preclinical study data (obtained by using an IC/PBS model in Sprague-Dawley female rats) have demonstrated normalization of urinary frequency indicating that LP may be a potent protectant of the bladder mucosa against inflammation and irritation. Intravesical LP has so far demonstrated an excellent safety profile and minimal toxicity at concentrations of 2 mg/ml. Thus, we hypothesize that intravesical instillation of LP may form a molecular film on bladder ulcer surfaces in patients with IC and provide a safe, effective, and minimally invasive treatment option to alleviating symptoms.

Interventions

  • BIOLOGICAL Liposomes

Study Locations (1)

Michigan

  • William Beaumont Hospital - Royal Oak

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2012-07
Est. Completion 2013-08
Phase NA

Sponsor

Kenneth Peters, MD

14 total trials

What the Registry Record Tells You About NCT01731470

The ClinicalTrials.gov registry entry for NCT01731470 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 362-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (96% lower). The listed sponsor is Kenneth Peters, MD, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 1 intervention - of which Liposomes is the first listed.

NCT01731470 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT01731470 about?

NCT01731470 is a clinical study titled "Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)". Interstitial cystitis/painful bladder syndrome (IC/PBS) is a poorly understood chronic disorder of unknown etiology consisting of irritative bladder symptoms and pelvic pain that dramatically affects quality of life. Preclinical study data (obtained by using an IC/PBS model in Sprague-Dawley female...

What is the current status of trial NCT01731470?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2012-07. Estimated completion is 2013-08.

What conditions does trial NCT01731470 study?

This clinical trial studies the following conditions: Interstitial Cystitis, Pelvic Pain.

What interventions are being tested in trial NCT01731470?

The interventions under investigation include: Liposomes (BIOLOGICAL).

Who is sponsoring clinical trial NCT01731470?

This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01731470 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.